Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.

Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M.

Science. 2006 Oct 20;314(5798):467-71.

2.

Two structurally atypical HEAT domains in the C-terminal portion of human eIF4G support binding to eIF4A and Mnk1.

Bellsolell L, Cho-Park PF, Poulin F, Sonenberg N, Burley SK.

Structure. 2006 May;14(5):913-23.

3.

NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4.

Waters LC, Böhm M, Veverka V, Muskett FW, Frenkiel TA, Kelly GP, Prescott A, Dosanjh NS, Klempnauer KH, Carr MD.

J Biomol NMR. 2006;36 Suppl 1:18. No abstract available.

PMID:
16518566
4.

Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.

Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH.

Mol Cell Biol. 2006 Feb;26(4):1297-306.

5.

Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.

Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y.

Cancer Res. 2005 Dec 15;65(24):11282-6.

6.

Structural basis for the enhancement of eIF4A helicase activity by eIF4G.

Oberer M, Marintchev A, Wagner G.

Genes Dev. 2005 Sep 15;19(18):2212-23.

7.

Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Jansen AP, Camalier CE, Colburn NH.

Cancer Res. 2005 Jul 15;65(14):6034-41.

8.

Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI.

Zakowicz H, Yang HS, Stark C, Wlodawer A, Laronde-Leblanc N, Colburn NH.

RNA. 2005 Mar;11(3):261-74. Epub 2005 Jan 20.

9.

Coot: model-building tools for molecular graphics.

Emsley P, Cowtan K.

Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32. Epub 2004 Nov 26.

PMID:
15572765
10.

Interaction between the NH2-terminal domain of eIF4A and the central domain of eIF4G modulates RNA-stimulated ATPase activity.

Korneeva NL, First EA, Benoit CA, Rhoads RE.

J Biol Chem. 2005 Jan 21;280(3):1872-81. Epub 2004 Nov 4.

11.

Refinement of macromolecular structures by the maximum-likelihood method.

Murshudov GN, Vagin AA, Dodson EJ.

Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55.

PMID:
15299926
12.
13.

The structural basis for the interaction between nonsense-mediated mRNA decay factors UPF2 and UPF3.

Kadlec J, Izaurralde E, Cusack S.

Nat Struct Mol Biol. 2004 Apr;11(4):330-7. Epub 2004 Mar 7.

PMID:
15004547
14.

Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.

Jansen AP, Camalier CE, Stark C, Colburn NH.

Mol Cancer Ther. 2004 Feb;3(2):103-10.

15.

SOLVE and RESOLVE: automated structure solution and density modification.

Terwilliger TC.

Methods Enzymol. 2003;374:22-37.

PMID:
14696367
16.

The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH.

Mol Cell Biol. 2003 Jan;23(1):26-37.

17.

DUG is a novel homologue of translation initiation factor 4G that binds eIF4A.

Göke A, Göke R, Knolle A, Trusheim H, Schmidt H, Wilmen A, Carmody R, Göke B, Chen YH.

Biochem Biophys Res Commun. 2002 Sep 13;297(1):78-82.

PMID:
12220511
18.

VHS domain -- a longshoreman of vesicle lines.

Lohi O, Poussu A, Mao Y, Quiocho F, Lehto VP.

FEBS Lett. 2002 Feb 20;513(1):19-23. Review.

19.

Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma.

Bauer C, Brass N, Diesinger I, Kayser K, Grässer FA, Meese E.

Int J Cancer. 2002 Mar 10;98(2):181-5.

20.

Crystal structure of the human nuclear cap binding complex.

Mazza C, Ohno M, Segref A, Mattaj IW, Cusack S.

Mol Cell. 2001 Aug;8(2):383-96.

Supplemental Content

Support Center